Your browser doesn't support javascript.
loading
Serum BCL2/IGH DNA in follicular lymphoma patients: a minimal residual disease marker.
Gocke, C D; Kopreski, M S; Benko, F A; Sternas, L; Kwak, L W.
Affiliation
  • Gocke CD; Department of Pathology, Penn State Geisinger Health System, Hershey, USA. cgocke@psghs.edu
Leuk Lymphoma ; 39(1-2): 165-72, 2000 Sep.
Article in En | MEDLINE | ID: mdl-10975396
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: DNA, Neoplasm / Immunoglobulin Joining Region / Lymphoma, Follicular / Immunoglobulin Heavy Chains / Genes, bcl-2 Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2000 Document type: Article Affiliation country: United States Country of publication: United States
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: DNA, Neoplasm / Immunoglobulin Joining Region / Lymphoma, Follicular / Immunoglobulin Heavy Chains / Genes, bcl-2 Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2000 Document type: Article Affiliation country: United States Country of publication: United States